Carve-Out of Select Drugs Sample Clauses

Carve-Out of Select Drugs. Exhibit 3 of this Contract contains the list of drugs and agents excluded from the Contractor’s capitation rate. These are referred to as “carved-out” drugs. The State’s fiscal agent pays claims for carved-out drugs on a fee-for-service basis for the Contractor’s members. While these drugs are not the financial responsibility of the Contractor, the Contractor shall ensure coordination of all Medicaid covered drugs and implement strategies to prevent duplication and fragmentation of care across the healthcare delivery system.
AutoNDA by SimpleDocs
Carve-Out of Select Drugs. The drugs described in this section are excluded from the Contractor’s capitation rate; these are referred to as “carved-out” drugs. The State’s fiscal agent pays claims for carved-out drugs on a fee-for-service basis for the Contractor’s members. While these drugs are not the financial responsibility of the Contractor, the Contractor shall ensure coordination of all Medicaid covered drugs and implement strategies to prevent duplication and fragmentation of care across the healthcare delivery system. Select drugs are carved out of the Hoosier Healthwise capitation rates for CY 2018 (full rating period). Below is a list of the drugs that have been carved out: ▪ Hepatitis C drugs (identified by a GPI-6 of 125350 or 123599) ▪ Spinraza ▪ Exondys 51 ▪ Kymriah ▪ Yescarta ▪ Luxturna ▪ Hemlibra ▪ Vertex cystic fibrosis drugs, including Orkambi, Kalydeco, and Symdeko Effective May 1, 2018 the state is also carving out hemophilia drugs with drug class ID of 8510 and those drugs with a Generic product indicator (GPI) beginning with 8510.
Carve-Out of Select Drugs. The drugs described in this section are excluded from the Contractor’s capitation rate; these are referred to as “carved-out” drugs. The State’s fiscal agent pays claims for carved-out drugs on a fee-for-service basis for the Contractor’s members. While these drugs are not the financial responsibility of the Contractor, the Contractor shall ensure coordination of all Medicaid covered drugs and implement strategies to prevent duplication and fragmentation of care across the healthcare delivery system. Select drugs are carved out of the Hoosier Healthwise capitation rates for CY 2018 (full rating period). Below is a list of the drugs that have been carved out:  Hepatitis C drugs (identified by a GPI-6 of 125350 or 123599)  Spinraza  Exondys 51  Kymriah  Yescarta  Luxturna  Hemlibra Effective May 1, 2018 the state is also carving out hemophilia drugs with drug class ID of 8510 and those drugs with a Generic product indicator (GPI) beginning with 8510.
Carve-Out of Select Drugs. The drugs described in this section are excluded from the Contractor’s capitation rate; these are referred to as “carved-out” drugs. The State’s fiscal agent pays claims for carved-out drugs on a fee-for-service basis for the Contractor’s members. While these drugs are not the financial responsibility of the Contractor, the Contractor shall ensure coordination of all Medicaid covered drugs and implement strategies to prevent duplication and fragmentation of care across the healthcare delivery system. Select drugs are carved out of the HIP capitation rates for CY 2018 (full rating period). Below is a list of the drugs that have been carved out:  Hepatitis C drugs (identified by a GPI-6 of 125350 or 123599)  Spinraza  Exondys 51  Kymriah  Yescarta  Luxturna  Hemlibra  Vertex cystic fibrosis drugs, including Orkambi, Kalydeco, and Symdeko Effective May 1, 2018 the state is also carving out hemophilia drugs with drug class ID of 8510 and those drugs with a Generic product indicator (GPI) beginning with 8510.
Carve-Out of Select Drugs. The drugs described in this section are excluded carved-out drugs on a fee-for- drugs are not the financial responsibility of the Contractor, the Contractor shall ensure coordination of all Medicaid covered drugs and implement strategies to prevent duplication and fragmentation of care across the healthcare delivery system. Select drugs are carved out of the Hoosier Healthwise capitation rates for CY 2018 (full rating period). Below is a list of the drugs that have been carved out: Hepatitis C drugs (identified by a GPI-6 of 125350 or 123599) Spinraza Exondys 51 Kymriah Yescarta Luxturna Hemlibra Effective May 1, 2018 the state is also carving out hemophilia drugs with drug class ID of 8510 and those drugs with a Generic product indicator (GPI) beginning with 8510.

Related to Carve-Out of Select Drugs

  • Random Drug Testing All employees covered by this Agreement shall be subject to random drug testing in accordance with Appendix D.

  • SHOP DRAWINGS, PRODUCT DATA AND SAMPLES 4.12.1 Shop Drawings are drawings, diagrams, schedules and other, data specially prepared for the Work by the Contractor or any Subcontractor, manufacturer, supplier or distributor to illustrate some portion of the Work. 4.12.2 Product Data are illustrations, standard schedules, performance charts, instructions, brochures, diagrams and other information furnished by the Contractor to illustrate a material, product or system for some portion of the Work. 4.12.3 Samples are physical examples which illustrate materials, equipment or workmanship and establish standards by which the Work will be judged. 4.12.4 The Contractor shall review, approve and submit, with reasonable promptness and in such sequence as to cause no delay in the Work or in the work of the State or any separate contractor, all Shop Drawings, Product Data and Samples required by the Contract Documents. 4.12.5 By approving and submitting Shop Drawings, Product Data and Samples, the Contractor represents that he / she has determined and verified all materials, field measurements, and field construction criteria related thereto, or will do so, and that he / she has checked and coordinated the information contained within such submittals with the requirements of the Work and of the Contract Documents. 4.12.6 The Contractor shall not be relieved of responsibility for any deviation from the requirements of the Contract Documents by the Architect's approval of Shop Drawings, Product Data or Samples under Subparagraph 2.2.7 of these General Conditions unless the Contractor has specifically informed the Architect and the State in writing of such deviation at the time of sub- mission and the Architect and the State has given written approval to the specific deviation. The Contractor shall not be relieved from responsibility for errors or omissions in the Shop Drawings, Product Data or Samples by the Architect's approval thereof. 4.12.7 The Contractor shall direct specific attention, in writing or on resubmitted Shop Drawings, Product Data or Samples, to revisions other than those requested by the Architect on previous submittals. 4.12.8 No portion of the Work requiring submission of a Shop Drawing, Product Data or Sample shall be commenced until the submittal has been approved by the Architect as provided in Subparagraph 2.2.7 of these General Conditions. All such portions of the Work shall be in accordance with approved submittals.

  • Please see the current Washtenaw Community College catalog for up-to-date program requirements Conditions & Requirements

  • CERTIFICATION REGARDING DRUG-FREE WORKPLACE REQUIREMENTS 1. The Contractor certifies that it will provide a drug-free workplace by: a. Publishing a statement notifying employees that the unlawful manufacture, distribution, dispensing, possession or use of a controlled substance is prohibited in the Contractor’s workplace and specifying the actions that will be taken against employees for violation of such prohibition;

  • Periodic Review of Costs of Environmental Compliance In the ordinary course of its business, the Company conducts a periodic review of the effect of Environmental Laws on the business, operations and properties of the Company and its subsidiaries, in the course of which it identifies and evaluates associated costs and liabilities (including, without limitation, any capital or operating expenditures required for clean-up, closure of properties or compliance with Environmental Laws or any permit, license or approval, any related constraints on operating activities and any potential liabilities to third parties). On the basis of such review and the amount of its established reserves, the Company has reasonably concluded that such associated costs and liabilities would not, individually or in the aggregate, result in a Material Adverse Change.

  • Contract Work Hours and Safety Standards Act The following clauses apply to any Federal-aid construction contract in an amount in excess of $100,000 and subject to the overtime provisions of the Contract Work Hours and Safety Standards Act. These clauses shall be inserted in addition to the clauses required by 29 CFR 5.5(a) or 29 CFR 4.6. As used in this paragraph, the terms laborers and mechanics include watchmen and guards.

  • Federal Occupational Safety and Health Law Contractor represents and warrants that all articles and services shall meet or exceed the safety standards established and promulgated under the Federal Occupational Safety and Health Act of 1970, as amended (29 U.S.C. Chapter 15).

  • CONTRACT WORK HOURS AND SAFETY STANDARDS As per the Contract Work Hours and Safety Standards Act (40 U.S.C. 3701-3708), where applicable, all Customer Purchase Orders in excess of ,000 that involve the employment of mechanics or laborers must include a provision for compliance with 40 U.S.C. 3702 and 3704, as supplemented by Department of Labor regulations (29 CFR Part 5). Under 40 U.S.C. 3702 of the Act, each contractor must be required to compute the wages of every mechanic and laborer on the basis of a standard work week of 40 hours. Work in excess of the standard work week is permissible provided that the worker is compensated at a rate of not less than one and a half times the basic rate of pay for all hours worked in excess of 40 hours in the work week. The requirements of 40 U.S.C. 3704 are applicable to construction work and provide that no laborer or mechanic must be required to work in surroundings or under working conditions which are unsanitary, hazardous or dangerous. These requirements do not apply to the purchases of supplies or materials or articles ordinarily available on the open market, or contracts for transportation or transmission of intelligence.

  • Wall Street Transparency and Accountability Act In connection with Section 739 of the Wall Street Transparency and Accountability Act of 2010 (“WSTAA”), the parties hereby agree that neither the enactment of WSTAA or any regulation under the WSTAA, nor any requirement under WSTAA or an amendment made by WSTAA, shall limit or otherwise impair either party’s otherwise applicable rights to terminate, renegotiate, modify, amend or supplement this Confirmation or the Agreement, as applicable, arising from a termination event, force majeure, illegality, increased costs, regulatory change or similar event under this Confirmation, the Equity Definitions incorporated herein, or the Agreement (including, but not limited to, rights arising from Change in Law, Hedging Disruption, Increased Cost of Hedging, an Excess Ownership Position, or Illegality (as defined in the Agreement)).

  • SITE VISITS AND RECORD REVIEW The Applicant shall allow authorized employees of the District, the Comptroller, the Appraisal District, and the State Auditor’s Office to have reasonable access to the Applicant’s Qualified Property and business records from the Application Review Start Date through the Final Termination Date, in order to inspect the project to determine compliance with the terms hereof or as necessary to properly appraise the Taxable Value of the Applicant’s Qualified Property. A. All inspections will be made at a mutually agreeable time after the giving of not less than ninety-six (96) hours prior written notice, and will be conducted in such a manner so as not to unreasonably interfere with either the construction or operation of the Applicant’s Qualified Property. B. All inspections may be accompanied by one or more representatives of the Applicant, and shall be conducted in accordance with the Applicant’s safety, security, and operational standards. Notwithstanding the foregoing, nothing contained in this Agreement shall require the Applicant to provide the District, the Comptroller, or the Appraisal District with any technical or business information that is proprietary, a trade secret, or is subject to a confidentiality agreement with any third party.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!